Abstract: A distance measurement method and system for LIDAR are provided, which includes: generating a frequency-swept light beam; splitting the frequency-swept light beam into a signal light beam and a local-oscillator light beam, where each of the signal light beam and the local-oscillator light beam includes first and second frequency-up phases, first and second frequency-down phases, slope of the first frequency-up phase is different from that of the second frequency-up phase, slope of the first frequency-down phase is different from that of the second frequency-down phase; emitting a signal light beam; receiving a reflected light beam; detecting beat frequencies of the frequency-up phases and the frequency-down phases between the local-oscillator light beam and the reflected light beam; and using two of beat frequencies of the frequency-up phases and frequency-down phases to measure the speed of the target object and/or the distance between the target object and the LIDAR.

Abstract: This application provides a laser measurement method and system. The method includes: generating a frequency-swept light beam; splitting the frequency-swept light beam into a signal light beam and a local oscillator light beam; emitting the signal light beam and obtaining a reflected light beam; mixing the local oscillator light beam and the reflected light beam; acquiring a beat frequency electrical signal; sampling the beat frequency electrical signal to obtain a first sampled signal sequence; generating a complex signal sequence based on the first sampled signal sequence; sampling the complex signal sequence to obtain a second sampled signal sequence; and generating a target beat frequency based on the first sampled signal sequence and the second sampled signal sequence.

Abstract: This application provide a rendering method and a related device, and relate to the field of electronic devices. In the method, a grouping result of a to-be-displayed frame is first determined. The grouping result may enable drawing duration of the to-be-displayed frame to be less than or equal to a sum of drawing duration of at least one application interface, namely, drawing duration required by the to-be-displayed frame when no grouping is performed. Then, a drawing task of the to-be-displayed frame is grouped based on the grouping result to obtain at least one drawing task group. Finally, the drawing task in the at least one drawing task group is processed by using at least one drawing thread to obtain at least one drawing result. The at least one drawing result is used to obtain an overall drawing result of the to-be-displayed frame through synthesis, to render the to-be-displayed frame.

Abstract: A microwave generation method for an aerosol-generating device includes: generating an Nth microwave signal by a microwave generation module, N being an integer greater than or equal to 1; detecting a feedback signal corresponding to the Nth microwave signal, and generating an adjusting signal according to the feedback signal; and adjusting a control signal according to the adjusting signal by a microwave control module as an adjusted control signal, and sending the adjusted control signal to the microwave generation module.

Abstract: In various embodiments, a tissue thickness compensator can comprise a compressible extracellular matrix and a bioabsorbable material dispersed within the extracellular matrix, wherein the bioapsorption of the bioabsorbable material is configured to leave behind channels in the extracellular matrix. The tissue thickness compensator can also comprise generation means for generating the ingrowth of tissue into the channels. In at least one embodiment, the tissue thickness compensator can comprise dissolvable wicking members which, when dissolved, can leave behind channels in the tissue thickness compensator. In certain embodiments, the tissue thickness compensator can comprise at least one rupturable capsule.

Abstract: In various embodiments, a tissue thickness compensator can comprise a compressible extracellular matrix and a bioabsorbable material dispersed within the extracellular matrix, wherein the bioapsorption of the bioabsorbable material is configured to leave behind channels in the extracellular matrix. The tissue thickness compensator can also comprise generation means for generating the ingrowth of tissue into the channels. In at least one embodiment, the tissue thickness compensator can comprise dissolvable wicking members which, when dissolved, can leave behind channels in the tissue thickness compensator. In certain embodiments, the tissue thickness compensator can comprise at least one rupturable capsule.

Abstract: In various embodiments, a tissue thickness compensator can comprise a compressible extracellular matrix and a bioabsorbable material dispersed within the extracellular matrix, wherein the bioapsorption of the bioabsorbable material is configured to leave behind channels in the extracellular matrix. The tissue thickness compensator can also comprise generation means for generating the ingrowth of tissue into the channels. In at least one embodiment, the tissue thickness compensator can comprise dissolvable wicking members which, when dissolved, can leave behind channels in the tissue thickness compensator. In certain embodiments, the tissue thickness compensator can comprise at least one rupturable capsule.

Abstract: In various embodiments, a tissue thickness compensator can comprise a compressible extracellular matrix and a bioabsorbable material dispersed within the extracellular matrix, wherein the bioapsorption of the bioabsorbable material is configured to leave behind channels in the extracellular matrix. The tissue thickness compensator can also comprise generation means for generating the ingrowth of tissue into the channels. In at least one embodiment, the tissue thickness compensator can comprise dissolvable wicking members which, when dissolved, can leave behind channels in the tissue thickness compensator. In certain embodiments, the tissue thickness compensator can comprise at least one rupturable capsule.

Abstract: In various embodiments, an end effector comprising a first jaw, a second jaw, an implantable arrangement, first cavities, and second cavities is disclosed. At least one of the first and second jaws is movable to compress tissue between the first jaw and second jaws. The implantable arrangement comprises a first layer and a second layer. The first layer and the second layer comprise a polymeric composition. The first cavities are defined in the first layer and interconnectedly form a permeable first layer. The first cavities releasably retain a first therapeutic agent configured to induce a first biological response in the tissue. The second cavities are defined in the second layer and interconnectedly form a permeable second layer. The second cavities releasably retain a second therapeutic agent configured to induce a second biological response in the tissue. The first therapeutic agent and the second therapeutic agent are different.

Abstract: The disclosure discloses a user biological feature authentication method and system. The method includes the following: a client sends an authentication request to a server; the client receives a speech password; acquires speech information and a face image of a user to be authenticated; the client judges whether the speech information is the same as the speech password, and judges whether the face image is valid; the client associates a speech information fragment to the face image under the condition that a judgment result is YES; the client calculates a digest value of the speech password, the speech information, a target image, associated information and a first moment; and the client sends an authentication content to the server. By the disclosure, the effect of improving ID authentication security in a biological feature recognition process is further achieved.

Abstract: A fastening system for fastening tissue that comprises a cartridge and an implant is disclosed. The cartridge comprises a cartridge body comprising removable fasteners. The implant comprises a first portion comprising a first absorbable polymer comprising a first compactness of first fibers and a first medicament releasably stored in the first compactness of the first fibers of the first portion. The implant further comprises a second portion comprising a second absorbable polymer comprising a second compactness of second fibers, wherein the second compactness is different than the first compactness. The second absorbable polymer is different than the first absorbable polymer. The implant further comprises a second medicament releasably stored in the second compactness of the second fibers of the second portion. The second medicament is different than the first medicament. The release of the second medicament and the release of the first medicament co-operatively produce a healing result.

Abstract: A tissue thickness compensator comprising at least one woven lattice can be positioned in the end effector of a surgical instrument. A fastener cartridge that is positioned in the end effector can comprise at least one cavity configured to receive a fastener. The fastener can be moveable between an initial position, wherein the fastener is at least partially position in a cavity, and a fired position, wherein the fastener is configured to compress a woven lattice of the tissue thickness compensator. The woven lattice can comprise a resilient material such that compression of the woven lattice generates a restoring force. The woven lattice can also comprise an axis that can laterally traverse the fastener cartridge, diagonally traverse the fastener cartridge, or intersect a deck surface of the fastener cartridge. The woven lattice can comprise a hydrophilic substance, which can expand when the woven lattice is severed by a cutting element.

Abstract: The disclosure discloses a user biological feature authentication method and system. The method includes the following: a client sends an authentication request to a server; the client receives a speech password; acquires speech information and a face image of a user to be authenticated; the client judges whether the speech information is the same as the speech password, and judges whether the face image is valid; the client associates a speech information fragment to the face image under the condition that a judgment result is YES; the client calculates a digest value of the speech password, the speech information, a target image, associated information and a first moment; and the client sends an authentication content to the server. By the disclosure, the effect of improving ID authentication security in a biological feature recognition process is further achieved.

Abstract: An end effector is disclosed. The end effector comprises a first jaw, a second jaw, wherein at least one of the first jaw and the second jaw is movable to compress tissue between the first jaw and the second jaw, and a cartridge body configured to receive a cutting member. The end effector further comprises a layer arrangement including a tissue contact surface and a plurality of therapeutic agents releasably contained within the layer arrangement, wherein each therapeutic agent is configured to either initially treat the tissue or sustainably treat the tissue in contact with the tissue contact surface, wherein one of the plurality of therapeutic agents is configured to be released by the cutting member, and wherein another of the plurality of therapeutic agents is configured to be released by an absorption process.

Abstract: A tissue thickness compensator comprising at least one woven lattice can be positioned in the end effector of a surgical instrument. A fastener cartridge that is positioned in the end effector can comprise at least one cavity configured to receive a fastener. The fastener can be moveable between an initial position, wherein the fastener is at least partially position in a cavity, and a fired position, wherein the fastener is configured to compress a woven lattice of the tissue thickness compensator. The woven lattice can comprise a resilient material such that compression of the woven lattice generates a restoring force. The woven lattice can also comprise an axis that can laterally traverse the fastener cartridge, diagonally traverse the fastener cartridge, or intersect a deck surface of the fastener cartridge. The woven lattice can comprise a hydrophilic substance, which can expand when the woven lattice is severed by a cutting element.

Abstract: A tissue thickness compensator comprising at least one woven lattice can be positioned in the end effector of a surgical instrument. A fastener cartridge that is positioned in the end effector can comprise at least one cavity configured to receive a fastener. The fastener can be moveable between an initial position, wherein the fastener is at least partially position in a cavity, and a fired position, wherein the fastener is configured to compress a woven lattice of the tissue thickness compensator. The woven lattice can comprise a resilient material such that compression of the woven lattice generates a restoring force. The woven lattice can also comprise an axis that can laterally traverse the fastener cartridge, diagonally traverse the fastener cartridge, or intersect a deck surface of the fastener cartridge. The woven lattice can comprise a hydrophilic substance, which can expand when the woven lattice is severed by a cutting element.

Abstract: A tissue thickness compensator can comprise a plurality of fibers. Such fibers can include a plurality of first fibers comprised of a first material and a plurality of second fibers comprised of a second material. A tissue thickness compensator can comprise a plurality of layers wherein each layer can be comprised of one or more medicaments. Certain embodiments are disclosed herein for manufacturing a tissue thickness compensator comprising fibers, for example.

Abstract: In various embodiments, a tissue thickness compensator can comprise a compressible extracellular matrix and a bioabsothable material dispersed within the extracellular matrix, wherein the bioapsorption of the bioabsorbable material is configured to leave behind channels in the extracellular matrix. The tissue thickness compensator can also comprise generation means for generating the ingrowth of tissue into the channels. In at least one embodiment, the tissue thickness compensator can comprise dissolvable wicking members which, when dissolved, can leave behind channels in the tissue thickness compensator. In certain embodiments, the tissue thickness compensator can comprise at least one rupturable capsule.

Abstract: A tissue thickness compensator may generally comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a third layer comprising a third medicament. The tissue thickness compensator may comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a reservoir comprising a third medicament disposed within the reservoir. The medicaments may be independently selected from a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a pharmaceutically active agent, a matrix metalloproteinase inhibitor, and combinations thereof. Articles of manufacture comprising the tissue thickness compensator and methods of making and using the tissue thickness compensator are also described.

Abstract: A staple cartridge assembly for use with a surgical stapler. The assembly has a cartridge body having a support portion with a plurality of staple cavities with openings. There is also a plurality of staples, wherein at least a portion of each the staple is removably stored within a the staple cavity. Each the staple is movable between an unfired position and a fired position, and is deformable between an unfired configuration and a fired configuration. The assembly also includes a compressible tissue thickness compensator configured to be captured within the staples. The compressible tissue thickness compensator at least partially covers the staple cavity openings. The compressed tissue thickness compensator is configured to assume different compressed heights within different the staples. The compressible tissue thickness compensator comprising a lyophilized foam having an oxygen generating agent embedded therein.